Skip to content

Guardant Health GH Total Liabilities

Total Liabilities at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$336.3M+11.7%
NeoGenomics logo
NeoGenomicsNEO
$566.51M+4.9%
Illumina logo
IlluminaILMN
$186M
Veracyte logo
VeracyteVCYT
$91.99M-23.6%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$85.51M+13.7%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$281.7M-12.1%

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$19.04B+255%
Enterprise value$19.65B+229%
P/S17.6×+11.2×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardant Health's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardant Health's total liabilities?
Guardant Health (GH) reported total liabilities of $2.1B in Q1 2026.
How has Guardant Health's total liabilities changed year-over-year?
Guardant Health's total liabilities increased by 31.4% year-over-year, from $1.6B to $2.1B.
What is the long-term trend for Guardant Health's total liabilities?
Over 5 years (2020 to 2025), Guardant Health's total liabilities has grown at a 18.2% compound annual growth rate (CAGR), from $916.19M to $2.11B.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.